Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Vaccine Developed to Stop Synthetic Opioids

Fentanyl patch products (Alcibiades, Wikimedia Commons)

17 February 2016. Fentanyl is a synthetic opioid drug for treating severe pain after surgery, and in some cases chronic pain, but is also highly addictive and increasingly abused, with growing numbers of overdose deaths. Researchers from Scripps Research Institute in La Jolla, California developed a vaccine . . . → Read More: Vaccine Developed to Stop Synthetic Opioids

Biotech Reviewing Stanford Immuno-Stem Cell Technology

Mark Davis (Stanford University)

16 February 2016. A biotechnology company in Los Angeles is evaluating a technology developed at Stanford University for transferring DNA of immune system cells to a patient’s own stem cells to produce immunotherapies for treating cancer. The agreement with Stanford gives ImmunoCellular Therapeutics Ltd. an option to license the . . . → Read More: Biotech Reviewing Stanford Immuno-Stem Cell Technology

Company Hosts Cancer Genome Cloud, Raises $45 Million

(National Heart, Lung, and Blood Institute, NIH)

16 February 2016. Seven Bridges Genomics, a computational biology company, unveiled its cloud-based cancer genome data sets, in one of three pilot tests for National Cancer Institute. The Cambridge, Massachusetts enterprise also raised $45 million in its first venture funding round.

National Cancer Institute, part of . . . → Read More: Company Hosts Cancer Genome Cloud, Raises $45 Million

Virtual Reality Seen Helping People with Depression

Scene from virtual reality scenario. Inset: participant in virtual reality exercise. (University College London)

15 February 2016. Individuals suffering from depression often express a high degree of self-criticism to the point it interferes with recovery from their disorder. Researchers from University College London showed in a pilot study that a virtual reality exercise . . . → Read More: Virtual Reality Seen Helping People with Depression

Harnessing Big Data for Precision Medicine

(DARPA, Wikimedia Commons)

13 February 2016. Precision medicine aims to match individualized genomic data with therapies to provide personalized treatments for people with disease. A panel today (13 February) at the American Association for Advancement of Science or AAAS 2016 annual meeting, described how big data — finding insights in large data sets . . . → Read More: Harnessing Big Data for Precision Medicine

What it Takes to Innovate in the Old Economy

Richard van Atta (A. Kotok)

12 February 2016. Innovation is important throughout the modern economy, particularly in established industries that may lack the excitement of hot new sectors like biotechnology. A panel at the American Association for the Advancement of Science, or AAAS 2016 annual meeting today (12 February) in Washington, D.C. examined . . . → Read More: What it Takes to Innovate in the Old Economy

Starting Tomorrow, Reporting Live from AAAS

Giant panda at the National Zoo, near the site of the 2016 AAAS annual meeting (A. Kotok)

11 February 2016. Starting tomorrow, Science & Enterprise will report live from the American Association for Advancement of Science annual meeting in Washington, D.C. Watch for updates during the weekend through Monday.

* * *

. . . → Read More: Starting Tomorrow, Reporting Live from AAAS

Alliance Creating PTSD Knowledge Base

(Allan Ajifo, Wikimedia Commons)

11 February 2016. A collaboration of three organizations and companies in the U.S. and Germany is building an authoritative and systematic collection of research on post-traumatic stress disorder or PTSD. The PTSD KnowledgeMap, as it’s called, is a project of Cohen Veterans Bioscience, Exaptive Inc,. and Fraunhofer Institute for . . . → Read More: Alliance Creating PTSD Knowledge Base

Gene Editing Enlisted to Fight Citrus Greening

(Hans, Pixabay)

11 February 2016. Plant scientists at University of California in Riverside plan to use genome editing to develop varieties of citrus fruit resistant to a bacterial disease devastating crops in the U.S. and other parts of the world. The five-year research project led by UC-Riverside plant pathologist Wenbo Ma is funded . . . → Read More: Gene Editing Enlisted to Fight Citrus Greening

$45M Raised by Protein Folding Drug Discovery Company

(Gerry Show, EnCor Biotechnology Inc./Wikimedia Commons)

10 February 2016. A company discovering new treatments that address errant folding of proteins causing neurological disorders raised $45 million in its first venture funding round. Yumanity Therapeutics, a spin-off enterprise from the Whitehead Institute affiliated with MIT, started in December 2014 and aims to discover therapies . . . → Read More: $45M Raised by Protein Folding Drug Discovery Company